-
公开(公告)号:EP3809959A1
公开(公告)日:2021-04-28
申请号:EP19737944.9
申请日:2019-06-19
-
公开(公告)号:EP4233697A2
公开(公告)日:2023-08-30
申请号:EP23178946.2
申请日:2019-06-19
发明人: BHAVSAR, Sonya Sanat , JOSEPHY, Noam , EDELMAN, Elazer R. , CHANG, Brian Yale , KELLER, Steven , EL KATERJI, Ahmad , TAN, Qing , MOYER, Christian , SHIP, Alexander
IPC分类号: A61B5/00
摘要: The systems and methods described herein determine metrics of cardiac performance via a mechanical circulatory support device and use the cardiac performance to calibrate, control and deliver mechanical circulatory support for the heart. The systems include a controller configured to operate the device, receive inputs indicative of device operating conditions and hemodynamic parameters, and determine vascular performance, including vascular resistance and compliance, and native cardiac output. The systems and methods operate by using the mechanical circulatory support device (e.g., a heart pump) to introduce controlled perturbations of the vascular system and, in response, determine heart parameters such as stroke volume, vascular resistance and compliance, left ventricular end diastolic pressure, and ultimately determine native cardiac output.
-
公开(公告)号:EP4233697A3
公开(公告)日:2023-09-27
申请号:EP23178946.2
申请日:2019-06-19
发明人: BHAVSAR, Sonya Sanat , JOSEPHY, Noam , EDELMAN, Elazer R. , CHANG, Brian Yale , KELLER, Steven , EL KATERJI, Ahmad , TAN, Qing , MOYER, Christian , SHIP, Alexander
IPC分类号: A61B5/02 , A61B5/0215 , A61B5/029 , A61B5/021 , A61B5/00 , A61M60/13 , A61M60/216 , A61M60/411 , A61M60/515 , A61M60/531 , A61M60/538 , A61M60/523
摘要: The systems and methods described herein determine metrics of cardiac performance via a mechanical circulatory support device and use the cardiac performance to calibrate, control and deliver mechanical circulatory support for the heart. The systems include a controller configured to operate the device, receive inputs indicative of device operating conditions and hemodynamic parameters, and determine vascular performance, including vascular resistance and compliance, and native cardiac output. The systems and methods operate by using the mechanical circulatory support device (e.g., a heart pump) to introduce controlled perturbations of the vascular system and, in response, determine heart parameters such as stroke volume, vascular resistance and compliance, left ventricular end diastolic pressure, and ultimately determine native cardiac output.
-
公开(公告)号:EP4440420A1
公开(公告)日:2024-10-09
申请号:EP22902212.4
申请日:2022-12-02
申请人: Abiomed, Inc.
发明人: MOYER, Christian , JORTBERG, Elise , BARDOT, Dawn , BHALA, Govind , MAIER, Maximilian , CHASE, Eric , GRIESSHAMMER, Christoph
CPC分类号: A61B5/02007 , A61B5/029 , A61B5/02108 , A61B5/0022 , A61B5/0205 , A61B5/7267 , A61B5/742 , A61B5/746 , A61B5/7275 , A61B5/02028
-
公开(公告)号:EP3634526A1
公开(公告)日:2020-04-15
申请号:EP18735114.3
申请日:2018-06-08
申请人: Abiomed, Inc.
IPC分类号: A61M1/10
-
公开(公告)号:EP4353299A2
公开(公告)日:2024-04-17
申请号:EP24153791.9
申请日:2018-06-08
申请人: Abiomed, Inc.
IPC分类号: A61M60/857
CPC分类号: A61M60/13 , A61M60/237 , A61M60/523 , A61M60/538 , A61M60/546 , A61M60/857 , A61M60/422 , A61M60/216 , A61M60/531 , A61M60/585
摘要: The systems, devices, and methods presented herein use a blood pump to obtain measurements of cardiac function. The system can quantify the functioning of the native heart by measuring certain parameters/signals such as aortic pressure or motor current, then calculate and display one or more cardiac parameters and heart function parameters, such as left ventricular pressure, left ventricular end diastolic pressure, or cardiac power output. These parameters provide valuable information to a user regarding current cardiac function, as well as positioning and function of the blood pump. In some embodiments, the system can act as a diagnostic and therapeutic tool. Providing cardiac parameters in real-time, along with warnings about adverse effects and recommendations to support cardiac function, such as increasing or decreasing the volumetric flow rate of blood pumped by the device, administering pharmaceutical therapies, and/or repositioning the blood pump allow clinicians to better support and treat cardiovascular disease.
-
-
-
-
-